查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564102

全球心血管植入市場

Cardiovascular Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

至2030年，全球心血管植入市場預計將達到435億美元

2023年全球心血管植入市場估計為311億美元，預計2030年將達到435億美元，2023-2030年分析期間複合年成長率為4.9%。支架是本報告分析的細分市場之一，預計複合年成長率為 5.5%，到分析期結束時將達到 187 億美元。分析期間 ICD 細分市場的複合年成長率預計為 3.9%。

美國市場預估成長85億美元，中國複合年成長率4.5%

預計 2023 年美國心血管植入市場規模將達 85 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達68億美元，2023-2030年分析期間複合年成長率為4.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.8% 和 3.7%。在歐洲，德國的複合年成長率預計為 3.9%。

全球心血管植入市場—主要趨勢與促進因素總結

心血管植入如何改變心臟疾病的治療？

心血管植入是一種專門的醫療設備，旨在透過支持或替換受損的心血管結構來治療和管理各種與心臟相關的疾病。這些設備包括調節異常心律（心律不整）的心律調節器、保持動脈開放以維持正常血流的支架以及用於更換心臟中患病或故障的瓣膜的心臟瓣膜。其他重要的心血管植入類型包括植入式心臟整流去顫器(ICD)，用於監測和糾正危及生命的心律不整；以及輔助人工心臟(VAD)，用於幫助衰弱的心臟將血液泵送到全身。心血管植入的重要性源自於它們能夠解決一些最嚴重且危及生命的心臟疾病。例如，心律調節器和 ICD 用於治療心律不整（心臟跳動過快、過慢或不規則）的患者，以幫助預防心臟麻痹。支架可以挽救患有冠狀動脈疾病的患者的生命，冠狀動脈疾病會導致冠狀動脈阻塞並導致心臟病發作。支架保持動脈暢通，確保血液持續流向心肌並防止嚴重併發症。同樣，心臟瓣膜植入用於取代狹窄（狹窄）或滲漏（逆流）的瓣膜（無論是機械瓣膜還是生物瓣膜），並幫助心臟維持有效的血液循環。隨著心臟衰竭、冠狀動脈疾病和瓣膜性心臟病等心臟病變得越來越普遍，心血管植入正在成為那些生活品質嚴重受限甚至過早死亡的患者最有效和可靠的治療選擇。其中之一。透過恢復正常的心臟功能或支持故障的心臟，這些植入可以顯著減輕呼吸急促、胸痛和疲勞等症狀，幫助患者恢復日常生活。

科技如何改善心血管植入？

技術進步大大提高了心血管植入的有效性、安全性和耐用性，使其更加可靠並可供更多患者使用。最重要的創新之一是開發更小、侵入性較小的設備。例如，現代心律心律調節器比以前的心律調節器小得多，並且無需進行侵入性手術即可植入，從而大大縮短了恢復時間和併發症的風險。同樣，藥物釋放型支架不僅可以物理支撐血管，還可以釋放藥物以防止動脈隨著時間的推移再次狹窄。在心臟瓣膜置換術領域，經導管瓣膜植入已成為傳統心臟直視手術的微創替代方案，使高風險患者能夠接受挽救生命的移植手術，而無需承擔大手術帶來的風險。此外，生物相容性材料的進步使植入更耐用、與人體更融合，減少了排斥反應的機會並改善了長期結果。穿戴式科技和遠端監測系統現已與許多植入整合，使醫療保健提供者能夠即時監測患者的心臟功能，並在必要時遠端調整治療計劃。這樣可以在出現問題時早期療育，從而顯著改善患者照護。此外，人工智慧和機器學習擴大融入這些設備中，透過分析患者資料並在異常導致嚴重健康事件之前檢測異常，提供了預測和預防併發症的潛力。此類創新正在重塑心血管治療領域，使植入比以往更安全、更有效、對患者更友善。

哪些趨勢正在塑造心血管植入市場？

幾個關鍵趨勢正在推動心血管植入市場的成長和開拓，這反映了醫療技術的進步、患者人口結構的變化以及醫療保健實踐的不斷發展。最重要的趨勢之一是對微創手術的需求不斷成長。隨著越來越多的患者和醫療保健提供者尋求侵入性較小的選擇，以避免與傳統手術相關的併發症和恢復時間，可以透過導管或小切口進行治療的心血管植入越來越受歡迎。這種趨勢在經導管主動脈瓣置換術(TAVR) 的使用不斷增加中尤其明顯。 TAVR 讓嚴重主動脈瓣狹窄患者無需進行心臟直視手術即可接受挽救生命的瓣膜植入術。影響市場的另一個主要趨勢是，由於人口老化以及肥胖、糖尿病和高血壓等文明病的增加，心血管疾病的盛行率不斷增加。隨著心臟病患者數量的不斷增加，對治療這些疾病的心血管植入的需求也不斷增加。這一需求也受到病患監測和資料分析的進步的推動，這些進步使得治療更加個人化和主動。允許臨床醫生即時追蹤植入性能的遠端監控技術變得越來越普遍，從而可以在必要時進行快速調整和介入。將人工智慧和機器學習融入植入設備的趨勢也產生了重大影響。這些技術使設備更加智慧、更有高效，使其能夠適應不斷變化的患者狀況、預測潛在問題並即時最佳化治療。此外，人們對開發生物分解性的支架和其他臨時心血管植入越來越感興趣，這些植入物在發揮其功能後會自發性溶解，從而可以減少進一步手術干預的需要。隨著這些趨勢的不斷發展，心血管植入在治療各種心臟病方面的能力和用途將進一步擴大。

推動心血管植入市場成長的因素有哪些？

心血管植入市場的成長受到技術進步、人口變化和不斷變化的醫療保健趨勢等多個因素的推動。最突出的促進因素之一是全球心血管疾病盛行率不斷上升，特別是隨著人口老化以及更多患者患有糖尿病、高血壓和肥胖等危險因子。隨著越來越多的患者需要長期治療心臟疾病，對心律調節器、支架和人工瓣膜等心血管植入的需求不斷增加。技術創新也是一個主要的成長要素。微創植入治療（例如經導管瓣膜置換術和無導線心律調節器）的發展擴大了適合這些治療的患者範圍，特別是無法接受傳統手術的高風險患者。另一個重要的促進因素是將遠端監控和人工智慧整合到可植入設備中。這些進步實現了即時資料追蹤和預測分析，使醫療保健提供者能夠持續監測患者狀況並及時調整治療計劃。透過這種積極主動的方法來管理心臟疾病可以改善患者的治療效果，並減少緊急介入和再入院的需要。此外，對患者客製化治療計劃和個人化醫療的日益關注正在導致針對個別患者需求的植入市場的開拓，進一步推動市場成長。旨在改善先進醫療技術取得的監管核准和政府措施也有助於心血管植入市場的擴張。在北美和歐洲等地區，簡化的監管流程正在加速將新型尖端植入引入診所。此外，新興市場醫療保健支出的增加正在改善先進心血管治療的可近性，並推動植入在這些地區的採用。最後，向基於價值的醫療保健的轉變強調患者的長期治療結果而不是短期治療，這鼓勵使用耐用且可靠的心血管植入，進一步促進市場成長。

受訪企業範例（29家知名企業）

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10903

Global Cardiovascular Implants Market to Reach US$43.5 Billion by 2030

The global market for Cardiovascular Implants estimated at US$31.1 Billion in the year 2023, is expected to reach US$43.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Stents, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$18.7 Billion by the end of the analysis period. Growth in the ICD segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.5 Billion While China is Forecast to Grow at 4.5% CAGR

The Cardiovascular Implants market in the U.S. is estimated at US$8.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Cardiovascular Implants Market - Key Trends and Drivers Summarized

How Are Cardiovascular Implants Transforming the Treatment of Heart Conditions?

Cardiovascular implants are specialized medical devices designed to treat and manage a wide range of heart-related conditions by either supporting or replacing damaged cardiovascular structures. These devices include a variety of tools such as pacemakers, which help regulate abnormal heart rhythms (arrhythmias), stents that keep arteries open to maintain proper blood flow, and heart valves that replace diseased or malfunctioning valves within the heart. Other important types of cardiovascular implants include implantable cardioverter defibrillators (ICDs), which monitor and correct life-threatening irregular heartbeats, and ventricular assist devices (VADs), which help a weakened heart pump blood throughout the body. The critical importance of cardiovascular implants stems from their ability to address some of the most severe and life-threatening heart conditions. For example, pacemakers and ICDs are used in patients suffering from arrhythmias, where the heart beats too fast, too slow, or irregularly, and can help prevent sudden cardiac arrest. Stents are lifesaving in cases of coronary artery disease, where blocked arteries can lead to heart attacks. By keeping these arteries open, stents ensure continuous blood flow to the heart muscle, preventing severe complications. Similarly, heart valve implants, whether mechanical or biological, are used to replace valves that are either narrowed (stenosis) or leaky (regurgitation), helping the heart to maintain efficient blood circulation. As heart conditions like heart failure, coronary artery disease, and valve disorders become more prevalent, cardiovascular implants have emerged as one of the most effective and reliable treatment options for patients who would otherwise face severe limitations in quality of life, or even premature death. By restoring normal heart function or supporting a failing heart, these implants help patients return to their daily activities with a significant reduction in symptoms like shortness of breath, chest pain, or fatigue.

How Has Technology Enhanced Cardiovascular Implants?

Technological advancements have greatly enhanced the effectiveness, safety, and durability of cardiovascular implants, making them more reliable and accessible for a broader range of patients. One of the most significant innovations has been the development of miniaturized, less invasive devices. For example, modern pacemakers are much smaller than their predecessors and can now be implanted without the need for invasive surgery, significantly reducing recovery times and the risk of complications. Similarly, drug-eluting stents have been developed to not only physically support blood vessels but also release medication to prevent the re-narrowing of arteries over time. In the field of heart valve replacement, transcatheter valve implantation has emerged as a minimally invasive alternative to traditional open-heart surgery, allowing high-risk patients to receive life-saving implants without the risks associated with major surgery. Additionally, advancements in biocompatible materials have made implants more durable and better integrated with the human body, reducing the chances of rejection and improving long-term outcomes. Wearable technology and remote monitoring systems are now integrated with many implants, allowing healthcare providers to monitor a patient's heart function in real time and adjust treatment plans remotely if necessary. This has significantly improved patient care by enabling early intervention when problems arise. Furthermore, artificial intelligence and machine learning are being incorporated into these devices, offering the potential to predict and prevent complications by analyzing patient data and detecting irregularities before they lead to serious health events. These innovations are reshaping the landscape of cardiovascular care, making implants safer, more effective, and more patient-friendly than ever before.

What Trends Are Shaping the Cardiovascular Implants Market?

Several key trends are driving the growth and development of the cardiovascular implants market, reflecting advancements in medical technology, changing patient demographics, and evolving healthcare practices. One of the most important trends is the increasing demand for minimally invasive procedures. As more patients and healthcare providers seek less invasive options to avoid the complications and recovery time associated with traditional surgeries, cardiovascular implants that can be delivered via catheters or small incisions are becoming more popular. This trend is particularly evident in the rising use of transcatheter aortic valve replacement (TAVR) procedures, which allow patients with severe aortic stenosis to receive life-saving valve implants without open-heart surgery. Another major trend shaping the market is the growing prevalence of cardiovascular diseases, driven by aging populations and the rise in lifestyle-related conditions such as obesity, diabetes, and hypertension. As the number of patients with heart disease continues to rise, so does the need for cardiovascular implants to treat these conditions. This demand is also fueled by advancements in patient monitoring and data analytics, which enable more personalized and proactive care. Remote monitoring technologies that allow clinicians to track the performance of implants in real-time are becoming increasingly common, allowing for quicker adjustments and interventions if necessary. The trend towards integrating AI and machine learning into implantable devices is also having a profound impact. These technologies allow devices to adapt to changing patient conditions, predict potential problems, and optimize therapy in real-time, making them smarter and more efficient. Moreover, there is growing interest in developing biodegradable stents and other temporary cardiovascular implants that can perform their function and then naturally dissolve, reducing the need for further surgical interventions. As these trends continue to evolve, they are likely to further expand the capabilities and applications of cardiovascular implants in treating a wide range of heart conditions.

What Factors Are Driving the Growth of the Cardiovascular Implants Market?

The growth in the cardiovascular implants market is driven by several factors linked to technological advancements, demographic shifts, and evolving healthcare trends. One of the most prominent drivers is the rising incidence of cardiovascular diseases globally, particularly in aging populations and among individuals with risk factors such as diabetes, hypertension, and obesity. As more patients require long-term management of heart conditions, the demand for cardiovascular implants, such as pacemakers, stents, and artificial valves, continues to rise. Technological innovations have also been a key growth driver. The development of minimally invasive implant procedures, such as transcatheter valve replacements and leadless pacemakers, has broadened the patient pool eligible for these treatments, particularly among high-risk individuals who cannot undergo traditional surgery. Another significant driver is the integration of remote monitoring and AI into implantable devices. These advancements allow for real-time data tracking and predictive analytics, enabling healthcare providers to monitor a patient’s condition continuously and make timely adjustments to treatment plans. This proactive approach to managing heart conditions improves patient outcomes and reduces the need for emergency interventions or hospital readmissions. Additionally, the increased focus on patient-specific treatment plans and personalized medicine has led to the development of implants tailored to individual patient needs, further boosting market growth. Regulatory approvals and government initiatives aimed at improving access to advanced medical technologies have also contributed to the expansion of the cardiovascular implants market. In regions such as North America and Europe, streamlined regulatory processes have accelerated the introduction of new, cutting-edge implants into clinical practice. Furthermore, increasing healthcare expenditure in emerging markets has improved access to advanced cardiovascular care, driving the adoption of implants in these regions. Finally, the shift towards value-based healthcare, where the focus is on long-term patient outcomes rather than short-term treatments, has incentivized the use of durable and reliable cardiovascular implants, further propelling market growth.

Select Competitors (Total 29 Featured) -

  • Abbott Laboratories
  • AMG International
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Dimensions Pty. Ltd.
  • Cardiac Science Corporation
  • Edwards Lifesciences Corporation
  • Japan Lifeline Co., Ltd.
  • Medtronic PLC
  • QualiMed Innovative Medizinprodukte GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiovascular Implants - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cardiovascular Diseases Spurs Demand for Cardiovascular Implants
    • Advancements in Biocompatible Materials Strengthen the Business Case for Next-Generation Implants
    • Aging Population and Increasing Incidence of Heart Failure Propel Growth of Cardiovascular Implants Market
    • Shift Toward Minimally Invasive Procedures Expands Addressable Market for Advanced Cardiovascular Implants
    • Here's How Wearable Technology and Remote Monitoring Capabilities Drive Adoption of Smart Cardiovascular Implants
    • Growing Adoption of Transcatheter Implant Procedures Spurs Demand for Innovative Cardiovascular Solutions
    • Post-Surgical Monitoring Capabilities Boost Demand for Intelligent Cardiovascular Implants
    • Growing Use of 3D Printing Technology in Cardiovascular Implants Propels Innovation and Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiovascular Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiovascular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for ICD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for ICD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Heart Valve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Heart Valve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Implanted Cardiac Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Implanted Cardiac Pacemaker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CRT Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CRT Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiovascular Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiovascular Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Cardiovascular Implants by Segment - Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Cardiovascular Implants by Segment - Percentage Breakdown of Value Sales for Stents, ICD, Heart Valve, Implanted Cardiac Pacemaker and CRT Device for the Years 2014, 2024 & 2030

IV. COMPETITION